“celgene” Archives

in
Entry Author Date Location
GSK’s Cancer Comeback Continues With Data for Multiple Myeloma Drug 08/23/19 National
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More 08/23/19 National
Oncorus Adds $79.5M to Steer Cancer-Fighting Virus to Human Testing 08/21/19 Boston
Skyhawk Inks Deal With Genentech for Cancer and Neuro Drug Discovery 07/16/19 Boston
Boston Tech Watch: Cisco, Acacia, Great Hill Partners & GNS Healthcare 07/12/19 Boston
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More 07/12/19 National
Bio Roundup: Merger Drama, FDA Trauma, Big IPOs, CRISPR Fights & More 06/28/19 National
With $45M Nurix Deal, Gilead Enters Crowded Protein Degradation Field 06/19/19 San Francisco
Bio Roundup: ASCO Wrap, Bluebird’s EU Tap, CRISPR Baby Risk & More 06/07/19 National
Grail’s Cook Steps Down, Former Juno Executive Bishop Named CEO 06/06/19 San Francisco
Bio Roundup: Opioids in Court, IPO Parade, Brain Cancer Bet & More 05/31/19 National
Ideaya and Bicycle Therapeutics IPOs Raise $110M for Cancer Drug R&D 05/23/19 San Francisco
Vividion Raises $82M to Advance Small Molecule Drugs to the Clinic 04/30/19 San Diego
It’s Tough to Find Drugs to Bind to RNA: Arrakis Nabs $75M to Help 04/18/19 Boston
Thwarting Opposition, Bristol Gets Shareholder OK for $74B Celgene Buyout 04/12/19 New York
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More 04/12/19 National
Celgene Files for FDA Approval of Blood Disease Drug 04/05/19 New York
Bio Roundup: Gottlieb’s Goodbye, AACR Recap, Migraine Drug Fight & More 04/05/19 National
AACR 2019 Roundup: Notes from a Weekend of Early Stage Cancer Results 04/03/19 National
Bio Roundup: Amyloid Angst, NASH News, Brammer Bagged & More 03/29/19 National
Amid Acquisition Drama, Celgene Resubmits MS Drug for FDA Approval 03/25/19 New York
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More 03/22/19 National
Bio Roundup: Golumbeski’s Legacy, CRISPR Moratorium, Rebate Week & More 03/15/19 National
Celgene Submits MS Drug for Approval in Europe, FDA Filing on Track 03/11/19 New York
The Life, Troubles, and Celgene Legacy of Deal Guru George Golumbeski 03/11/19 National
Bio Roundup: Pharma in DC, Bristol-Cel in Trouble, Roche Gets A Spark 03/01/19 National
Bristol-Myers’ $74B Celgene Buyout Faces Opposition from Wellington 02/27/19 New York
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More 02/22/19 National
Starboard Ups Bristol-Myers Stake Ahead of Vote on Celgene Deal 02/20/19 New York
AbbVie Joins Myeloma Race with $90M Deal for Rights to Teneobio Drug 02/11/19 San Francisco
Page 2 of 19 « previous page · next page »